ArticleDrug safety2026
The Evaluation of Transformer Models for the Detection of Adverse Drug Events: A Benchmark Study Using Dutch Free-Text Documents of Hospitalized Patients.
Article in Drug safety, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
introductionAdverse drug events (ADEs) are a leading cause of preventable patient harm in hospitals. Because they are often recorded only in clinical free-text documents, retrieval and quantification are significantly limited. Automating ADE detection with natural language processing (NLP) is promising. Recent work shows that bidirectional encoder representations from transformers (BERT)-based models outperform bidirectional long short-term memory (Bi-LSTM) models and even larger generative pretrained transformers while being more computationally efficient. However, most ADE-NLP research focuses on the English language, often applies metrics less suitable for rare outcomes such as ADEs, and lacks external validation.
objectivesTo evaluate four transformer models for the detection of ADEs by reusing Dutch clinical free-text documents and create a benchmark with realistic clinical scenarios, appropriate performance measures, and external validation.
methodsWe used three anonymized datasets: (1) Dutch ADE corpus with 102 densely annotated progress notes of patients admitted to the intensive care unit (ICU) from one Dutch academic hospital, (2) ICU AKI corpus with 411 sparsely annotated ICU notes from the same hospital, and (3) WINGS corpus with 100 discharge letters of internal medicine patients from two Dutch non-academic hospitals, labeled for ADE presence. A Bi-LSTM model and four transformer-based Dutch or multilingual encoder models (BERTje, RobBERT-base, MedRoBERTa.nl, NuNER) were trained for named entity recognition (NER) and relation classification (RC) using the Dutch ADE corpus. We used fivefold cross validation with 60%/20%/20% train/validation/test splits and performed hyperparameter tuning on the first fold for NER and across all folds for RC. We evaluated our ADE RC models internally using gold standard (two-step task) and predicted entities (end-to-end task). In addition, all models were externally validated using WINGS Corpus on detecting ADEs at the document level. We report both micro- and macro-averaged F1 scores, to account for ADE rarity.
resultsIn our internal validation, MedRoBERTa.nl achieved the best performance, with macro-averaged F1 score of 0.63 using gold standard entities and 0.62 using predicted entities, while all models reached micro-averaged F1 scores ± 0.99. MedRoBERTa.nl also performed the best in our external validation, with recall range 0.67-0.74 using predicted entities (end-to-end task), meaning that between 67% and 74% of discharge letters with ADEs were detected.
conclusionsThe Dutch domain-specific MedRoBERTa.nl showed the best performance in detecting ADEs in Dutch clinical texts, and in line with previous studies in English language settings, outperformed Bi-LSTM. The inclusion of external validation highlights its generalization potential. Our findings also underline the need for further model improvement and use of performance measures suited to rare outcomes such as ADEs, as micro-averaged F1 scores inflate performance compared with macro-averaged F1 scores. We provide a robust and clinically meaningful benchmark approach for NLP-based ADE detection in clinical free-text documents. Our approach can serve as a guidance for future NLP benchmarks in ADE domain.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.